The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India.

Saved in:

Bibliographic Details
Title:	The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India.
Authors:	Babu, Govind¹, Saldanha, Smitha Carol¹, Kuntegowdanahalli Chinnagiriyappa, Lakshmaiah¹, Jacob, Linu Abraham¹, Mallekavu, Suresh Babu¹, Dasappa, Loknatha¹, Kiran, Pretesh Rohan², Sreevatsa, Aparna¹, Appachu, Sandhya¹, Unnikrishnan, Vineetha¹, Arroju, Venugopal¹
Source:	Chemotherapy Research & Practice. 1/27/2016, p1-5. 5p. 5 Charts.
Database:	Academic Search Ultimate

Description
ISSN:	20902107
DOI:	10.1155/2016/3439707